Journal of Nuclear Medicine March 2026, jnumed.125.271601; DOI: https://doi.org/10.2967/jnumed.125.271601 ...

C-X-C motif chemokine receptor 4 (CXCR4) is a transmembrane chemokine receptor involved in various biologic processes, including tumor growth, metastasis, and the homing and retention of hematopoietic ...

Prostate-specific membrane antigen (PSMA) PET/CT is widely used to monitor response during [177Lu]Lu-PSMA radiopharmaceutical therapy (RPT) in metastatic castration-resistant prostate cancer (mCRPC), ...

Journal of Nuclear Medicine March 2026, jnumed.125.271296; DOI: https://doi.org/10.2967/jnumed.125.271296 ...

Recent converging evidence suggests that the brain may receive stimuli and possibly modulate tumor progression via the vagus nerve. The present study aimed to compare brain metabolism in patients with ...

Individuals with a solitary lung lesion smaller than 30 mm in axial diameter who had a PET/CT examination between September 2002 and June 2004 were included in this retrospective study. Patients with ...

Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

This study was performed in accordance with and approved by the Animal Care and Use Committee of RIKEN Kobe Institute (MAH18-02). Adult male C57BL/6J mice (8–10 wk old) were purchased from Clea Japan ...

Quantitative 18F-FDG PET is increasingly being recognized as an important tool for diagnosis, determination of prognosis, and response monitoring in oncology. However, PET quantification with, for ...

Because of its high expression in several tumor types, the gastrin/cholecystokinin subtype 2 receptor (CCK-2R) is of interest as a target for diagnostic imaging and peptide receptor radionuclide ...